Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Thermo Fisher Scientific Inc. (NYSE:TMO)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Thermo Fisher Scientific Inc. for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Cash Flow Statement
Quarterly Data

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Thermo Fisher Scientific Inc., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
3 months ended: Jun 27, 2020 Mar 28, 2020 Dec 31, 2019 Sep 28, 2019 Jun 29, 2019 Mar 30, 2019 Dec 31, 2018 Sep 29, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jul 1, 2017 Apr 1, 2017 Dec 31, 2016 Oct 1, 2016 Jul 2, 2016 Apr 2, 2016 Dec 31, 2015 Sep 26, 2015 Jun 27, 2015 Mar 28, 2015
Net income
Loss from discontinued operations
Income from continuing operations
Depreciation of property, plant and equipment
Amortization of acquisition-related intangible assets
Depreciation and amortization (legacy)
Change in deferred income taxes
Gain on sales of businesses
Stock-based compensation
Loss on early extinguishment of debt
Tax benefits from stock-based compensation awards
Other non-cash expenses, net
Accounts receivable
Inventories
Other assets
Accounts payable
Other liabilities
Contributions to retirement plans
Other
Changes in assets and liabilities, excluding the effects of acquisitions and dispositions
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Acquisitions, net of cash acquired
Proceeds from sale of business, net of cash divested
Purchase of property, plant and equipment
Proceeds from sale of property, plant and equipment
Other investing activities, net
Net cash used in investing activities
Net proceeds from issuance of debt
Repayment of debt
Proceeds from issuance of commercial paper
Repayments of commercial paper
Increase (decrease) in commercial paper, net (legacy)
Purchases of company common stock
Dividends paid
Net proceeds from issuance of company common stock
Net proceeds from issuance of company common stock under employee stock plans
Tax benefits from stock-based compensation awards
Other financing activities, net
Net cash provided by (used in) financing activities
Net cash used in discontinued operating activities
Net cash used in discontinued operations
Exchange rate effect on cash
Increase (decrease) in cash, cash equivalents and restricted cash

Based on: 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-01), 10-Q (filing date: 2019-08-02), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-02), 10-Q (filing date: 2018-08-03), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-28), 10-Q (filing date: 2017-11-03), 10-Q (filing date: 2017-08-04), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06), 10-K (filing date: 2016-02-25), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-31), 10-Q (filing date: 2015-05-01).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Thermo Fisher Scientific Inc.’s net cash provided by operating activities decreased from Q4 2019 to Q1 2020 but then increased from Q1 2020 to Q2 2020 not reaching Q4 2019 level.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Thermo Fisher Scientific Inc.’s net cash used in investing activities increased from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Thermo Fisher Scientific Inc.’s net cash provided by (used in) financing activities increased from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.